Figure 3From: Pressure for drug development in lysosomal storage disorders – a quantitative analysis thirty years beyond the US orphan drug actYear of orphan drug designation for compounds intended to treat lysosomal storage diseases. A) by technology platform. B) by disease.Back to article page